Crooke, Stanley T.
Ionis Pharmaceuticals (United States)
11 papers on CoChatORCID 0000-0002-4260-1520
Most cited papers
- Verified
RNA-Targeted Therapeutics
Crooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 841
- Verified
Antisense technology: an overview and prospectus
Crooke, S. T., Baker, B. F., Crooke, R. M., & Liang, X.-H. (2021) · Nature Reviews Drug Discovery
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 775
- Verified
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Viney, N. J., van Capelleveen, J. C., Geary, R. S., Xia, S., Tami, J. A., Yu, R. Z., Marcovina, S. M., Hughes, S. G., Graham, M. J., Crooke, R. M., et al. (2016) · The Lancet
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 754
- Verified
Cellular uptake and trafficking of antisense oligonucleotides
Crooke, S. T., Wang, S., Vickers, T. A., Shen, W., & Liang, X.-H. (2017) · Nature Biotechnology
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 582
- Verified
Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents
Vickers, T. A., Koo, S., Bennett, C. F., Crooke, S. T., Dean, N. M., & Baker, B. F. (2003) · Journal of Biological Chemistry
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 461
- Verified
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 417
- Verified
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans
Graham, M. J., Lee, R. G., Bell, T. A., Fu, W., Mullick, A. E., Alexander, V. J., Singleton, W., Viney, N., Geary, R., Su, J., et al. (2013) · Circulation Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 377
- Verified
Phosphorothioate modified oligonucleotide–protein interactions
Crooke, S. T., Vickers, T. A., & Liang, X.-H. (2020) · Nucleic Acids Research
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 372
- Verified
The Effects of 2′- O -Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
Crooke, S. T., Baker, B. F., Witztum, J. L., Kwoh, T. J., Pham, N. C., Salgado, N., McEvoy, B. W., Cheng, W., Hughes, S. G., Bhanot, S., et al. (2017) · Nucleic Acid Therapeutics
RNA Interference and Gene DeliveryPlatelet Disorders and Treatments
Cited by 129
- Verified
Integrated Assessment of the Clinical Performance of GalNAc 3 -Conjugated 2′- O -Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
Crooke, S. T., Baker, B. F., Xia, S., Yu, R. Z., Viney, N. J., Wang, Y., Tsimikas, S., & Geary, R. S. (2019) · Nucleic Acid Therapeutics
RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry
Cited by 127
- Verified
Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
Nakada, M. T., Stadel, J. M., Poksay, K. S., & Crooke, S. T. (1987) · Molecular Pharmacology
Receptor Mechanisms and SignalingEstrogen and related hormone effects
Cited by 78
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free